BITS Pilani

  • Page last updated on Wednesday, May 17, 2023

Research Interest

banner
Research Interest

Research Interest


 Tuberculosis drug discovery
Main TB targets: Enzymes involved in DNA synthesis, cell wall synthesis, signaling pathway, dormancy, shikimate pathway, amino acid biosynthesis.
 
Host directed TB therapy 
 
Other antimicrobial drug discovery 
 
Antibacterial drugs: ESKAPE organisms majorly Staphylococcus aureus and Pseudomonas aeruginosa
 

 


Collaborative Research Scientist at:

1. Karolinska Institute, Sweden.

2. N.I.I. New Delhi, India.

3. Institute of Science and Technology for Tuberculosis, Technopuc, Brazil 
 
4. The Global Alliance for TB Drug Development Inc. NY.
 
5. Institute of Medical Biology, Lodz, Poland. 
 




Quick Links

    An Institution Deemed to be University estd. vide Sec.3 of the UGC Act,1956 under notification # F.12-23/63.U-2 of Jun 18,1964

    © 2024 Centre for Software Development,SDET Unit, BITS-Pilani, India.

    Designed and developed by fractal | ink design studios